By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

AMAG Pharmaceuticals, Inc. 

1100 Winter Street

Waltham  Massachusetts  02451  U.S.A.
Phone: 617-498–3300 Fax: 617-499-3361


SEARCH JOBS

Founded in 1981, AMAG Pharmaceuticals is committed to improving the health outcomes of patients through the development and commercialization of specialty pharmaceutical products.

AMAG currently markets a therapeutic intravenous iron compound for the treatment of iron deficiency anemia in adult patients with chronic kidney disease (CKD) and an oral rinse for the management of oral mucositis in the United States. To learn more about our products, click here. Along with driving organic growth of its lead product, AMAG intends to expand its portfolio with additional commercial-stage specialty pharmaceuticals. The company is seeking complementary products that leverage the company's commercial footprint and focus on hematology and oncology centers and hospital infusion centers.
Our iron oxide particles are composed of bioavailable iron that is easily absorbed by the body and incorporated into the body's iron stores. As a result, products using our core technology are well suited for use in intravenous iron replacement therapy.


Key Statistics


Email: contactus@amagpharma.com
Ownership: Public

Web Site: AMAG Pharmaceuticals, Inc.
Employees: 51-200
Symbol: AMAG
 




Segment
Pharmaceuticals





Company News
AMAG Pharmaceuticals, Inc. (AMAG) To Host Conference Call On May 5, 2015 At 8:00 A.M. ET To Discuss Financial Results For The Quarter Ended March 31, 2015 4/23/2015 10:38:09 AM
AMAG Pharmaceuticals, Inc. (AMAG) To Participate In The 14th Annual Needham Healthcare Conference 4/8/2015 8:16:40 AM
AMAG Pharmaceuticals, Inc. (AMAG) Announces New Management Appointments 4/2/2015 7:10:37 AM
AMAG Pharmaceuticals, Inc. (AMAG) Announces Closing Of $201 Million Public Offering Of Common Stock Including Full Exercise Of Underwriters' Option 3/4/2015 7:07:16 AM
AMAG Pharmaceuticals, Inc. (AMAG) To Participate In The Cowen and Company 35th Annual Healthcare Conference 2/27/2015 7:21:28 AM
AMAG Pharmaceuticals, Inc. (AMAG) Prices Public Offering Of $175 Million Of Common Stock 2/26/2015 6:20:32 AM
AMAG Pharmaceuticals, Inc. (AMAG) Announces Proposed Public Offering Of $125 Million Of Common Stock 2/25/2015 7:47:42 AM
AMAG Pharmaceuticals, Inc. (AMAG) To Participate In The 2015 RBC Capital Markets' Healthcare Conference 2/20/2015 7:46:05 AM
AMAG Pharmaceuticals, Inc. (AMAG) Announces Final Fourth Quarter And Year End 2014 Financial Results 2/10/2015 7:58:41 AM
AMAG Pharmaceuticals, Inc. (AMAG) To Participate In The Leerink Global Healthcare Conference 2/6/2015 10:17:20 AM
12345678910...
//-->